Stephen Chang, PhD
PhD in Biological Chemistry, Molecular Biology, and Biochemistry, University of California, Irvine
Dr. Chang served as Chief Scientific Officer of Stemgent upon the company’s founding in 2008. He was previously the CEO of Multicell Technologies and continues as a director of this company. Dr. Chang is president of CURES, a coalition dedicated to ensuring the safety, research, and development of innovative lifesaving medications. He is also a board member of Histogen, Inc., a privately held company in regenerative medicine.